Provention Bio
Ashleigh Palmer, co-founder and CEO of Provention Bio, is a successful life sciences entrepreneur and innovator with more than 30 years’ experience and expertise in corporate strategy formulation/transactions, preclinical/clinical drug evaluation, and product development/commercialization. Ashleigh has served as CEO for multiple biopharmaceutical companies (both private and public) and has held numerous board director and chairman positions. He is also Founder and President of Creative BioVentures™ Corp. (CBV), a strategic advisory firm serving the biopharmaceutical industry.
This person is not in any offices
Provention Bio
Clinical-stage biopharma company focused on the interception and prevention of immune-mediated disease including type 1 diabetes, celiac disease, and lupus.